Indolinone derivatives

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7223783
APP PUB NO 20060142281A1
SERIAL NO

11358305

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I) ##STR00001## in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 have the meanings given in the specification, are receptor tyrosine kinase inhibitors useful in the treatment of proliferative disorders, such as cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THERAVANCE BIOPHARMA R&D IP LLC901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Briesewitz, Roger Mountain View, CA 20 191
Griffin, John H Atherton, CA 75 855
Wray, Jonathan W San Francisco, CA 25 188

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation